BUPIVACAINE HYDROCHLORIDE IN DEXTROSE

BUPIVACAINE HYDROCHLORIDE IN DEXTROSE was reported 7626 times

BUPIVACAINE HYDROCHLORIDE IN DEXTROSE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ARACHNOID WEB 6 0.4286
1 OCULOCARDIAC REFLEX 5 0.3125
2 ANTERIOR SPINAL ARTERY SYNDROME 24 0.2857
3 MATERNAL EXPOSURE DURING DELIVERY 254 0.2563
4 INFUSION SITE FIBROSIS 5 0.2500
5 PLATELET AGGREGATION INHIBITION 15 0.1630
6 PURTSCHER RETINOPATHY 13 0.1585
7 CATHETER SITE GRANULOMA 9 0.1579
8 INSPIRATORY CAPACITY DECREASED 41 0.1480
9 ACUTE MACULAR NEURORETINOPATHY 25 0.1462
10 OBSTETRIC PROCEDURE COMPLICATION 5 0.1351
11 BEZOLD-JARISCH REFLEX 5 0.1316
12 MATERNAL USE OF ILLICIT DRUGS 5 0.1316
13 HORNER'S SYNDROME 10 0.1205
14 LOCAL ANAESTHETIC SYSTEMIC TOXICITY 127 0.1196
15 CONUS MEDULLARIS SYNDROME 7 0.1077
16 FOETAL EXPOSURE DURING DELIVERY 73 0.1077
17 SPINAL ANAESTHESIA 8 0.1039
18 CHONDROLYSIS 46 0.0979
19 PAROPHTHALMIA 23 0.0966
20 HARLEQUIN SYNDROME 7 0.0959
21 VASCULAR RESISTANCE SYSTEMIC DECREASED 11 0.0821
22 IMPLANT SITE EXTRAVASATION 63 0.0802
23 MEDICAL DEVICE SITE PAIN 44 0.0782
24 LAGOPHTHALMOS 30 0.0733
25 BASELINE FOETAL HEART RATE VARIABILITY DISORDER 4 0.0727
26 FEMORAL NERVE INJURY 5 0.0694
27 SPINAL CORD INFARCTION 30 0.0680
28 OVERLAP SYNDROME 46 0.0657
29 MEDICAL DEVICE SITE DISCHARGE 10 0.0654
30 PHRENIC NERVE PARALYSIS 14 0.0639
31 MEDICAL DEVICE SITE ERYTHEMA 8 0.0625
32 ANAESTHETIC COMPLICATION 161 0.0599
33 POST PROCEDURAL HYPOTENSION 5 0.0588
34 ANAESTHETIC COMPLICATION CARDIAC 4 0.0580
35 BRIEF PSYCHOTIC DISORDER WITH MARKED STRESSORS 9 0.0559
36 CAUDA EQUINA SYNDROME 39 0.0508
37 OPEN GLOBE INJURY 8 0.0485
38 MEDICAL DEVICE SITE SWELLING 8 0.0462
39 RHYTHM IDIOVENTRICULAR 15 0.0462
40 UTERINE ATONY 12 0.0458
41 SYSTEMIC TOXICITY 9 0.0439
42 ANAPHYLACTOID SYNDROME OF PREGNANCY 4 0.0417
43 NEUROMUSCULAR BLOCK PROLONGED 15 0.0407
44 NEONATAL RESPIRATORY ACIDOSIS 6 0.0395
45 BRADYCARDIA FOETAL 32 0.0385
46 PROCEDURAL HYPOTENSION 32 0.0376
47 BRACHIAL PLEXUS INJURY 6 0.0373
48 MENINGITIS CHEMICAL 8 0.0364
49 BRACHIAL PLEXOPATHY 8 0.0362
50 MYOPATHY TOXIC 22 0.0356
51 CARDIAC OUTPUT INCREASED 6 0.0351
52 ARACHNOIDITIS 24 0.0347
53 AIRWAY COMPLICATION OF ANAESTHESIA 9 0.0342
54 DEVICE DAMAGE 26 0.0326
55 SPINAL CORD OEDEMA 12 0.0324
56 NEUROMUSCULAR BLOCKADE 7 0.0312
57 IMPLANT SITE MASS 6 0.0305
58 POST LAMINECTOMY SYNDROME 5 0.0291
59 IMPLANT SITE HAEMATOMA 7 0.0287
60 EXTRADURAL HAEMATOMA 37 0.0280
61 MEAN ARTERIAL PRESSURE DECREASED 7 0.0277
62 PARALYSIS FLACCID 6 0.0274
63 FOETAL HEART RATE DECELERATION ABNORMALITY 19 0.0269
64 ANAESTHETIC COMPLICATION NEUROLOGICAL 23 0.0254
65 INTRAOCULAR PRESSURE FLUCTUATION 5 0.0254
66 POST LUMBAR PUNCTURE SYNDROME 26 0.0250
67 HYPONATRAEMIC ENCEPHALOPATHY 5 0.0248
68 DEVICE BATTERY ISSUE 16 0.0243
69 DELAYED RECOVERY FROM ANAESTHESIA 23 0.0243
70 CONJUNCTIVAL OEDEMA 23 0.0224
71 DEVICE INFUSION ISSUE 54 0.0218
72 IMPLANT SITE DISCHARGE 8 0.0213
73 INFUSION SITE MASS 23 0.0212
74 IMPLANT SITE EROSION 6 0.0204
75 EXTRADURAL ABSCESS 16 0.0204
76 OPHTHALMOPLEGIA 32 0.0203
77 HYPERTENSIVE ENCEPHALOPATHY 12 0.0202
78 RADICULAR PAIN 7 0.0201
79 UREAPLASMA INFECTION 8 0.0196
80 IMPLANT SITE PAIN 87 0.0195
81 SPINAL EPIDURAL HAEMATOMA 11 0.0187
82 LOSS OF PROPRIOCEPTION 6 0.0186
83 HERPES SIMPLEX REACTIVATION 7 0.0184
84 SENSORIMOTOR DISORDER 9 0.0181
85 PLATELET DYSFUNCTION 5 0.0180
86 APGAR SCORE LOW 23 0.0178
87 LEFT VENTRICLE OUTFLOW TRACT OBSTRUCTION 6 0.0172
88 CATHETER RELATED COMPLICATION 19 0.0169
89 ECLAMPSIA 6 0.0163
90 CEREBROSPINAL FLUID LEAKAGE 30 0.0162
91 CORNEAL REFLEX DECREASED 6 0.0160
92 SYMMETRICAL DRUG-RELATED INTERTRIGINOUS AND FLEXURAL EXANTHEMA 13 0.0158
93 NERVE BLOCK 9 0.0154
94 PARAPLEGIA 44 0.0152
95 PROCEDURAL NAUSEA 12 0.0149
96 SPINAL CORD INJURY 26 0.0149
97 SPHINCTER OF ODDI DYSFUNCTION 6 0.0146
98 MEDICAL DEVICE SITE INFECTION 9 0.0145
99 ANAL SPHINCTER ATONY 6 0.0140
100 PROCEDURAL VOMITING 9 0.0138
101 IMPLANT SITE SWELLING 14 0.0137
102 DOSE CALCULATION ERROR 8 0.0137
103 BRAIN STEM SYNDROME 10 0.0133
104 THERAPEUTIC PRODUCT EFFECT PROLONGED 6 0.0132
105 AREFLEXIA 34 0.0127
106 DEVICE ALARM ISSUE 23 0.0127
107 NORMAL NEWBORN 68 0.0125
108 PROCEDURAL HEADACHE 5 0.0122
109 IMPLANT SITE SCAR 9 0.0120
110 IMPLANT SITE INFECTION 28 0.0120
111 TRYPTASE INCREASED 8 0.0112
112 THERAPEUTIC PRODUCT INEFFECTIVE FOR UNAPPROVED INDICATION 5 0.0111
113 INCISION SITE ERYTHEMA 5 0.0109
114 DRUG EFFECT PROLONGED 6 0.0109
115 POSTPARTUM HAEMORRHAGE 14 0.0104
116 VASOPLEGIA SYNDROME 17 0.0104
117 ALLODYNIA 12 0.0103
118 SEROMA 13 0.0102
119 INCISION SITE PAIN 12 0.0102
120 DIAPHRAGMATIC PARALYSIS 6 0.0100
121 ELECTROMECHANICAL DISSOCIATION 8 0.0100
122 LOW BIRTH WEIGHT BABY 79 0.0099
123 RETINAL ARTERY OCCLUSION 25 0.0099
124 CANCER PAIN 25 0.0098
125 KOUNIS SYNDROME 22 0.0097
126 HYPERCAPNIA 29 0.0096
127 RESPIRATORY DEPRESSION 118 0.0096
128 HYPERAESTHESIA 79 0.0096
129 ADRENAL SUPPRESSION 8 0.0095
130 EXOPHTHALMOS 20 0.0093
131 INTRACRANIAL HYPOTENSION 6 0.0092
132 UNMASKING OF PREVIOUSLY UNIDENTIFIED DISEASE 10 0.0091
133 MYELITIS 14 0.0090
134 SOFT TISSUE NECROSIS 6 0.0087
135 SPINAL CORD COMPRESSION 34 0.0087
136 SURGICAL PROCEDURE REPEATED 6 0.0087
137 MEDICAL DEVICE SITE DISCOMFORT 7 0.0087
138 FOETAL HEART RATE ABNORMAL 8 0.0086
139 AUTONOMIC NERVOUS SYSTEM IMBALANCE 25 0.0085
140 MYOCLONUS 102 0.0085
141 MYELITIS TRANSVERSE 12 0.0085
142 AIR EMBOLISM 4 0.0085
143 FANCONI SYNDROME 12 0.0085
144 SINUS ARREST 13 0.0083
145 MEDICAL DEVICE DISCOMFORT 25 0.0082
146 DIPLEGIA 16 0.0081
147 FOETAL DISTRESS SYNDROME 17 0.0080
148 APNOEA 62 0.0080
149 IMPLANT SITE ERYTHEMA 8 0.0077
150 MUSCLE NECROSIS 7 0.0077
151 PARESIS 17 0.0076
152 NO THERAPEUTIC RESPONSE 91 0.0075
153 BRONCHOSTENOSIS 4 0.0073
154 PARAPARESIS 13 0.0073
155 ANASTOMOTIC LEAK 5 0.0072
156 LIVE BIRTH 60 0.0072
157 LUPUS VULGARIS 9 0.0071
158 SENSORY LOSS 57 0.0071
159 DEAFNESS BILATERAL 12 0.0071
160 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 62 0.0070
161 IATROGENIC INJURY 9 0.0070
162 DEVICE KINK 25 0.0069
163 MYELOPATHY 13 0.0068
164 AXILLARY PAIN 10 0.0067
165 PREMATURE BABY 202 0.0067
166 BRADYARRHYTHMIA 11 0.0067
167 SPINAL CORD DISORDER 11 0.0067
168 PREMATURE DELIVERY 106 0.0067
169 GRANULOMA 23 0.0066
170 RESPIRATORY ACIDOSIS 26 0.0066
171 TACHYARRHYTHMIA 16 0.0064
172 PERFORMANCE STATUS DECREASED 29 0.0062
173 MUSCLE SPASTICITY 76 0.0062
174 CATHETER SITE PAIN 16 0.0062
175 DEEP VEIN THROMBOSIS POSTOPERATIVE 12 0.0060
176 AMAUROSIS 5 0.0059
177 HYPOGONADISM 6 0.0059
178 HYPOTHERMIA 60 0.0059
179 DEVICE FAILURE 90 0.0059
180 BLOOD PRESSURE IMMEASURABLE 9 0.0059
181 WRONG PRODUCT ADMINISTERED 39 0.0058
182 APALLIC SYNDROME 4 0.0055
183 SEDATION COMPLICATION 14 0.0055
184 VASOSPASM 5 0.0054
185 COMPLEX REGIONAL PAIN SYNDROME 8 0.0054
186 RESPIRATORY RATE DECREASED 17 0.0054
187 SKIN GRAFT 5 0.0054
188 SKIN TEST POSITIVE 5 0.0054
189 SEDATION 140 0.0053
190 CATHETER SITE RELATED REACTION 4 0.0053
191 EXPOSURE DURING PREGNANCY 328 0.0053
192 VITH NERVE PARALYSIS 6 0.0053
193 HAEMODYNAMIC INSTABILITY 39 0.0051
194 HYPORESPONSIVE TO STIMULI 6 0.0051
195 INADEQUATE ANALGESIA 43 0.0051
196 PARALYSIS 71 0.0050
197 DEAFNESS NEUROSENSORY 16 0.0049
198 MONOPLEGIA 21 0.0048
199 SACROILIITIS 9 0.0048
200 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 5 0.0047
201 CAESAREAN SECTION 54 0.0046
202 ENDOTRACHEAL INTUBATION 13 0.0046
203 HYPERAMMONAEMIC ENCEPHALOPATHY 8 0.0046
204 PREMATURE SEPARATION OF PLACENTA 7 0.0045
205 POST PROCEDURAL COMPLICATION 87 0.0045
206 HYPERTROPHIC CARDIOMYOPATHY 7 0.0045
207 QUADRIPLEGIA 9 0.0044
208 CYSTITIS INTERSTITIAL 7 0.0043
209 PULSELESS ELECTRICAL ACTIVITY 18 0.0043
210 CATHETER SITE SWELLING 4 0.0043
211 FOETAL GROWTH RESTRICTION 26 0.0043
212 MATERNAL EXPOSURE DURING PREGNANCY 379 0.0042
213 HYPERTENSIVE EMERGENCY 5 0.0042
214 NEONATAL RESPIRATORY DISTRESS SYNDROME 15 0.0042
215 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 14 0.0042
216 MENINGITIS BACTERIAL 6 0.0042
217 PREMATURE RUPTURE OF MEMBRANES 10 0.0041
218 CONVERSION DISORDER 8 0.0041
219 STRIDOR 12 0.0041
220 UNRESPONSIVE TO STIMULI 105 0.0041
221 PROCEDURAL COMPLICATION 31 0.0040
222 HYPOPNOEA 14 0.0040
223 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 69 0.0040
224 ADMINISTRATION SITE EXTRAVASATION 4 0.0040
225 PERIPHERAL SENSORIMOTOR NEUROPATHY 5 0.0040
226 BRAIN HYPOXIA 4 0.0040
227 MYOCLONIC EPILEPSY 6 0.0040
228 BREAKTHROUGH PAIN 9 0.0039
229 BLADDER DYSFUNCTION 4 0.0039
230 MONOPARESIS 7 0.0039
231 BRUGADA SYNDROME 4 0.0039
232 GENERALISED TONIC-CLONIC SEIZURE 64 0.0039
233 WOUND DEHISCENCE 13 0.0038
234 BUNDLE BRANCH BLOCK LEFT 16 0.0038
235 HYPOVOLAEMIA 22 0.0038
236 MENTAL STATUS CHANGES 104 0.0037
237 BLOOD PRESSURE SYSTOLIC DECREASED 17 0.0037
238 HYPOGLYCAEMIA NEONATAL 6 0.0037
239 BRADYCARDIA 195 0.0037
240 QUADRIPARESIS 6 0.0036
241 SUBSTANCE-INDUCED PSYCHOTIC DISORDER 8 0.0036
242 RECTAL ABSCESS 6 0.0036
243 ANAL INCONTINENCE 32 0.0036
244 MEDICAL DEVICE COMPLICATION 26 0.0035
245 ARTERIOSPASM CORONARY 14 0.0035
246 RETINITIS 6 0.0035
247 PRODUCT MONITORING ERROR 5 0.0035
248 METHAEMOGLOBINAEMIA 8 0.0035
249 VENTRICULAR HYPOKINESIA 11 0.0034
250 URINARY RETENTION 114 0.0034
251 FACET JOINT SYNDROME 11 0.0034
252 HYPERTHERMIA MALIGNANT 5 0.0034
253 ILEUS PARALYTIC 15 0.0034
254 VOCAL CORD PARALYSIS 6 0.0033
255 BRADYPNOEA 9 0.0033
256 PRODUCT PACKAGING CONFUSION 8 0.0033
257 DYSAESTHESIA 10 0.0033
258 DRUG WITHDRAWAL SYNDROME 281 0.0032
259 MATERNAL EXPOSURE TIMING UNSPECIFIED 12 0.0032
260 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 7 0.0032
261 BREECH PRESENTATION 4 0.0032
262 PERONEAL NERVE PALSY 18 0.0032
263 COMPLICATION ASSOCIATED WITH DEVICE 46 0.0032
264 PRE-ECLAMPSIA 15 0.0032
265 NECROTISING FASCIITIS 11 0.0031
266 DEVICE POWER SOURCE ISSUE 9 0.0031
267 DISLOCATION OF VERTEBRA 7 0.0031
268 CATATONIA 16 0.0030
269 INJECTION SITE ATROPHY 5 0.0030
270 PARADOXICAL DRUG REACTION 11 0.0030
271 ATRIOVENTRICULAR BLOCK SECOND DEGREE 9 0.0030
272 DRUG TOLERANCE 15 0.0030
273 CEREBELLAR INFARCTION 5 0.0030
274 MOTOR DYSFUNCTION 30 0.0029
275 PULSE ABSENT 14 0.0029
276 URINARY HESITATION 7 0.0029
277 BLOOD PH DECREASED 5 0.0029
278 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 6 0.0029
279 MENINGITIS ASEPTIC 13 0.0029
280 PUPIL FIXED 5 0.0029
281 CIRCULATORY COLLAPSE 49 0.0029
282 STAPHYLOCOCCUS TEST POSITIVE 6 0.0028
283 DEVICE CONNECTION ISSUE 6 0.0028
284 ANAPHYLACTIC SHOCK 73 0.0028
285 KYPHOSIS 5 0.0028
286 SWOLLEN JOINT COUNT INCREASED 9 0.0028
287 FOETAL EXPOSURE DURING PREGNANCY 229 0.0028
288 NUCLEAR MAGNETIC RESONANCE IMAGING ABNORMAL 9 0.0027
289 GRAND MAL CONVULSION 25 0.0027
290 FAECAL INCONTINENCE 13 0.0027
291 HYPOTONIA 27 0.0027
292 INTERVERTEBRAL DISCITIS 5 0.0026
293 HYPOXIA 93 0.0026
294 MECHANICAL VENTILATION 5 0.0026
295 VENTRICULAR FIBRILLATION 29 0.0026
296 ATROPHY 5 0.0026
297 VITREOUS HAEMORRHAGE 7 0.0025
298 HYPOTENSION 506 0.0025
299 BRAIN INJURY 25 0.0025
300 STUPOR 8 0.0025
301 HYPOVENTILATION 8 0.0025
302 HYPERPARATHYROIDISM SECONDARY 6 0.0024
303 ISCHAEMIA 11 0.0024
304 NEURALGIA 58 0.0024
305 POTENTIATING DRUG INTERACTION 8 0.0024
306 CREPITATIONS 7 0.0023
307 NERVE INJURY 26 0.0023
308 MEDICAL DEVICE PAIN 5 0.0023
309 HEARING IMPAIRED 14 0.0023
310 ACUTE PULMONARY OEDEMA 13 0.0023
311 COMPARTMENT SYNDROME 6 0.0023
312 RADICULOPATHY 6 0.0023
313 ENDOMETRIAL CANCER 5 0.0023
314 BRAIN DEATH 7 0.0023
315 SINUS TACHYCARDIA 32 0.0023
316 YAWNING 6 0.0022
317 RHEUMATIC FEVER 10 0.0022
318 ATRIOVENTRICULAR BLOCK COMPLETE 15 0.0022
319 SEROTONIN SYNDROME 43 0.0022
320 LARYNGOSPASM 6 0.0022
321 COMPUTERISED TOMOGRAM ABNORMAL 5 0.0022
322 DISTRIBUTIVE SHOCK 5 0.0022
323 DEVICE OCCLUSION 31 0.0022
324 HICCUPS 18 0.0022
325 CLONUS 6 0.0022
326 CARDIAC ARREST 181 0.0022
327 NEUROTOXICITY 38 0.0022
328 NEUROLOGICAL DECOMPENSATION 5 0.0022
329 ARTHRITIS INFECTIVE 10 0.0022
330 PREMATURE LABOUR 12 0.0021
331 VENTRICULAR TACHYCARDIA 35 0.0021
332 NEUROLOGICAL SYMPTOM 12 0.0021
333 HYPERTONIA 12 0.0021
334 ANAPHYLACTIC REACTION 114 0.0021
335 DEPRESSED LEVEL OF CONSCIOUSNESS 81 0.0020
336 STRABISMUS 6 0.0020
337 STATUS EPILEPTICUS 23 0.0020
338 JOINT RANGE OF MOTION DECREASED 27 0.0020
339 BRAIN HERNIATION 6 0.0020
340 ANORECTAL DISORDER 4 0.0020
341 DIPLOPIA 52 0.0020
342 METABOLIC ENCEPHALOPATHY 6 0.0020
343 RESPIRATORY ARREST 55 0.0020
344 TYPE I HYPERSENSITIVITY 7 0.0020
345 VASODILATATION 5 0.0020
346 EMBOLISM VENOUS 6 0.0020
347 ARTHRITIS BACTERIAL 8 0.0019
348 NEPHROGENIC ANAEMIA 9 0.0019
349 MUSCLE RIGIDITY 23 0.0019
350 NYSTAGMUS 10 0.0019
351 MIOSIS 15 0.0019
352 URINARY INCONTINENCE 55 0.0019
353 DRUG EXPOSURE DURING PREGNANCY 63 0.0019
354 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 12 0.0018
355 DECUBITUS ULCER 15 0.0018
356 SUBDURAL HAEMATOMA 26 0.0018
357 DELIRIUM 63 0.0018
358 RESPIRATORY DISTRESS 50 0.0018
359 HYPERAMMONAEMIA 9 0.0018
360 PRODUCT ADMINISTRATION ERROR 36 0.0018
361 SINUS BRADYCARDIA 17 0.0018
362 MUSCULAR WEAKNESS 197 0.0017
363 HYPERTONIC BLADDER 5 0.0017
364 HYPOAESTHESIA 259 0.0017
365 FORMICATION 12 0.0017
366 HYPERREFLEXIA 6 0.0017
367 PULMONARY TOXICITY 12 0.0017
368 MATERNAL DRUGS AFFECTING FOETUS 13 0.0017
369 SENSORY DISTURBANCE 27 0.0017
370 WITHDRAWAL SYNDROME 70 0.0017
371 CYANOSIS 26 0.0017
372 EMERGENCY CARE 5 0.0016
373 VENTRICULAR ARRHYTHMIA 6 0.0016
374 BLOOD DISORDER 13 0.0016
375 DRUG TOXICITY 22 0.0016
376 BRONCHOSPASM 23 0.0016
377 PROCEDURAL PAIN 44 0.0016
378 THERAPY NON-RESPONDER 71 0.0016
379 HYPERTHERMIA 12 0.0016
380 MYOSITIS 14 0.0016
381 RHEUMATOID FACTOR POSITIVE 9 0.0016
382 STRESS CARDIOMYOPATHY 9 0.0015
383 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 12 0.0015
384 VENTRICULAR EXTRASYSTOLES 16 0.0015
385 ACUTE RESPIRATORY FAILURE 29 0.0015
386 METASTASES TO SPINE 5 0.0015
387 SPINAL COLUMN STENOSIS 7 0.0015
388 POSTOPERATIVE WOUND INFECTION 10 0.0015
389 DUODENAL ULCER PERFORATION 11 0.0015
390 WOUND INFECTION 16 0.0015
391 EXTRAVASATION 6 0.0015
392 WRONG DRUG ADMINISTERED 13 0.0015
393 CARDIOTOXICITY 13 0.0015
394 ATELECTASIS 14 0.0014
395 HEART RATE ABNORMAL 8 0.0014
396 BLEPHAROSPASM 9 0.0014
397 BONE EROSION 5 0.0014
398 FACIAL PARESIS 5 0.0014
399 ABSCESS LIMB 6 0.0014
400 DEVICE DISLOCATION 61 0.0014
401 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 76 0.0014
402 WHEELCHAIR USER 6 0.0013
403 BRAIN OEDEMA 17 0.0013
404 RESPIRATORY FAILURE 98 0.0013
405 LEFT VENTRICULAR DYSFUNCTION 9 0.0013
406 MUSCLE INJURY 11 0.0013
407 HEPATIC NECROSIS 5 0.0013
408 PAROSMIA 10 0.0013
409 BODY TEMPERATURE DECREASED 13 0.0013
410 SCIATICA 21 0.0013
411 EYE MOVEMENT DISORDER 9 0.0013
412 PULMONARY CONGESTION 17 0.0013
413 OLIGURIA 8 0.0013
414 TACHYCARDIA 114 0.0013
415 LOSS OF CONSCIOUSNESS 164 0.0013
416 PROCEDURAL HAEMORRHAGE 5 0.0013
417 FAECALOMA 7 0.0013
418 AGITATION 93 0.0013
419 ENCEPHALOPATHY 31 0.0013
420 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 9 0.0013
421 INTRAOCULAR PRESSURE INCREASED 16 0.0013
422 GRIP STRENGTH DECREASED 11 0.0012
423 DYSTONIA 24 0.0012
424 MUSCLE TIGHTNESS 20 0.0012
425 PERIPHERAL VENOUS DISEASE 5 0.0012
426 PERIPHERAL ISCHAEMIA 5 0.0012
427 ANAPHYLACTOID REACTION 5 0.0012
428 BLOOD PRESSURE DECREASED 80 0.0012
429 ACCIDENTAL OVERDOSE 44 0.0012
430 MENINGITIS 8 0.0012
431 INTERVERTEBRAL DISC DEGENERATION 11 0.0012
432 DISORIENTATION 46 0.0012
433 APLASTIC ANAEMIA 6 0.0011
434 HYPERHIDROSIS 147 0.0011
435 HYPERCHOLESTEROLAEMIA 11 0.0011
436 THERAPEUTIC RESPONSE DECREASED 69 0.0011
437 AUTOIMMUNE DISORDER 11 0.0011
438 CARDIO-RESPIRATORY ARREST 47 0.0011
439 INCORRECT ROUTE OF DRUG ADMINISTRATION 40 0.0011
440 MEDICATION ERROR 62 0.0011
441 APPARENT DEATH 4 0.0011
442 SUSPECTED OFF LABEL USE 5 0.0011
443 THERAPEUTIC PRODUCT EFFECT DELAYED 5 0.0011
444 METABOLIC ACIDOSIS 35 0.0011
445 SPINAL COMPRESSION FRACTURE 9 0.0011
446 OXYGEN SATURATION DECREASED 61 0.0011
447 BLOOD PRESSURE DIASTOLIC DECREASED 8 0.0011
448 BREAST CANCER STAGE III 7 0.0011
449 BURSITIS 13 0.0011
450 ADRENAL INSUFFICIENCY 13 0.0011
451 HELICOBACTER INFECTION 11 0.0011
452 PAIN 656 0.0011
453 MYOCARDIAL ISCHAEMIA 12 0.0011
454 DEVICE MALFUNCTION 74 0.0011
455 COMA 50 0.0010
456 SOMNOLENCE 210 0.0010
457 JOINT DISLOCATION 11 0.0010
458 RALES 6 0.0010
459 TACHYPNOEA 14 0.0010
460 PRODUCT LABEL CONFUSION 6 0.0010
461 APHASIA 31 0.0010
462 FEELING OF BODY TEMPERATURE CHANGE 6 0.0010
463 MYDRIASIS 13 0.0010
464 PULMONARY OEDEMA 45 0.0010
465 ASPIRATION 11 0.0010
466 APHONIA 14 0.0010
467 OVERDOSE 216 0.0010
468 TOXIC ENCEPHALOPATHY 5 0.0010
469 RETINAL HAEMORRHAGE 7 0.0010
470 SMALL INTESTINAL OBSTRUCTION 12 0.0010
471 PERSONALITY CHANGE 9 0.0010
472 BENIGN PROSTATIC HYPERPLASIA 5 0.0010
473 FOETAL DEATH 5 0.0010
474 PERIORBITAL OEDEMA 5 0.0010
475 DRUG INTERACTION 152 0.0010
476 PARTIAL SEIZURES 5 0.0010
477 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 9 0.0009
478 HEART RATE DECREASED 33 0.0009
479 LETHARGY 54 0.0009
480 MASS 13 0.0009
481 NERVOUS SYSTEM DISORDER 29 0.0009
482 ATRIOVENTRICULAR BLOCK FIRST DEGREE 4 0.0009
483 HYDROCEPHALUS 5 0.0009
484 PRODUCT PREPARATION ISSUE 6 0.0009
485 ADVERSE DRUG REACTION 82 0.0009
486 SPINAL OSTEOARTHRITIS 8 0.0009
487 BLADDER DISORDER 9 0.0009
488 MUSCULOSKELETAL PAIN 47 0.0009
489 EYELID PTOSIS 9 0.0009
490 ILEUS 11 0.0009
491 SUBARACHNOID HAEMORRHAGE 9 0.0009
492 PNEUMOTHORAX 14 0.0009
493 IMPAIRED GASTRIC EMPTYING 12 0.0009
494 STAPHYLOCOCCAL INFECTION 29 0.0009
495 SCAR 15 0.0009
496 BUNDLE BRANCH BLOCK RIGHT 4 0.0009
497 PARAESTHESIA 137 0.0009
498 SOCIAL AVOIDANT BEHAVIOUR 5 0.0009
499 HYPERVENTILATION 5 0.0009
500 EYELID OEDEMA 10 0.0009
501 POST PROCEDURAL HAEMORRHAGE 10 0.0009
502 FOLLICULITIS 9 0.0009
503 ERYTHEMA MULTIFORME 8 0.0009
504 HALLUCINATION, VISUAL 18 0.0009
505 DISSEMINATED INTRAVASCULAR COAGULATION 12 0.0009
506 INCONTINENCE 9 0.0009
507 OSTEOARTHRITIS 36 0.0008
508 OEDEMA 46 0.0008
509 THERMAL BURN 6 0.0008
510 SPINAL DISORDER 8 0.0008
511 ATAXIA 10 0.0008
512 HAND DEFORMITY 11 0.0008
513 DRUG EFFECT DECREASED 45 0.0008
514 ACCIDENTAL UNDERDOSE 12 0.0008
515 PANIC REACTION 6 0.0008
516 APHAGIA 4 0.0008
517 HEPATITIS CHOLESTATIC 5 0.0008
518 MUSCLE TWITCHING 19 0.0008
519 IMPAIRED HEALING 27 0.0008
520 FACIAL PARALYSIS 7 0.0008
521 TOXICITY TO VARIOUS AGENTS 138 0.0008
522 RED BLOOD CELL SEDIMENTATION RATE INCREASED 9 0.0008
523 HAEMATOMA 21 0.0008
524 DISCOMFORT 49 0.0008
525 OFF LABEL USE 701 0.0008
526 GROIN PAIN 7 0.0008
527 ROAD TRAFFIC ACCIDENT 33 0.0008
528 TROPONIN INCREASED 6 0.0008
529 COORDINATION ABNORMAL 11 0.0008
530 SEIZURE 91 0.0008
531 ACIDOSIS 6 0.0008
532 SCREAMING 5 0.0008
533 C-REACTIVE PROTEIN ABNORMAL 5 0.0008
534 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 8 0.0008
535 PROCTALGIA 5 0.0008
536 ATRIOVENTRICULAR BLOCK 6 0.0008
537 PRESCRIBED OVERDOSE 15 0.0008
538 LIP DRY 7 0.0008
539 EXOSTOSIS 7 0.0008
540 RESTLESSNESS 28 0.0008
541 TORSADE DE POINTES 6 0.0008
542 NEUROLEPTIC MALIGNANT SYNDROME 9 0.0008
543 WALKING AID USER 5 0.0008
544 OBESITY 12 0.0008
545 MOVEMENT DISORDER 24 0.0007
546 ACUTE MYOCARDIAL INFARCTION 22 0.0007
547 ANAL ABSCESS 4 0.0007
548 ULCER HAEMORRHAGE 5 0.0007
549 DEVICE LEAKAGE 32 0.0007
550 SHOCK HAEMORRHAGIC 6 0.0007
551 CONFUSIONAL STATE 118 0.0007
552 ABASIA 18 0.0007
553 BACK PAIN 168 0.0007
554 PEMPHIGUS 9 0.0007
555 HIP ARTHROPLASTY 11 0.0007
556 EXTRASYSTOLES 5 0.0007
557 DYSKINESIA 29 0.0007
558 MUSCLE SPASMS 130 0.0007
559 BURNING SENSATION 49 0.0007
560 DRUG ADMINISTRATION ERROR 21 0.0007
561 CONVULSION 39 0.0007
562 LOWER LIMB FRACTURE 13 0.0007
563 HYPOPHOSPHATAEMIA 5 0.0007
564 RESPIRATORY RATE INCREASED 6 0.0007
565 TINNITUS 31 0.0007
566 DRUG-INDUCED LIVER INJURY 21 0.0007
567 DYSARTHRIA 25 0.0007
568 HYPOAESTHESIA ORAL 10 0.0007
569 CLOSTRIDIUM DIFFICILE COLITIS 7 0.0007
570 END STAGE RENAL DISEASE 12 0.0007
571 DEVICE ISSUE 59 0.0007
572 IRRITABLE BOWEL SYNDROME 14 0.0007
573 SHOCK 15 0.0007
574 UROSEPSIS 6 0.0006
575 NERVE COMPRESSION 6 0.0006
576 DEVICE RELATED INFECTION 10 0.0006
577 UNEVALUABLE EVENT 49 0.0006
578 ALTERED STATE OF CONSCIOUSNESS 14 0.0006
579 COGNITIVE DISORDER 30 0.0006
580 FLANK PAIN 6 0.0006
581 VISUAL ACUITY REDUCED 21 0.0006
582 HALLUCINATION, AUDITORY 10 0.0006
583 SLEEP APNOEA SYNDROME 12 0.0006
584 MALNUTRITION 7 0.0006
585 BLOOD PRESSURE FLUCTUATION 15 0.0006
586 HYPERTENSION 131 0.0006
587 HEART RATE INCREASED 61 0.0006
588 BRADYPHRENIA 4 0.0006
589 ACUTE CORONARY SYNDROME 5 0.0006
590 ELECTROLYTE IMBALANCE 7 0.0006
591 BLOOD PRESSURE INCREASED 92 0.0006
592 RESPIRATORY DISORDER 18 0.0006
593 CARDIAC FAILURE ACUTE 4 0.0006
594 SPINAL PAIN 7 0.0006
595 PERICARDITIS 10 0.0006
596 INTERVERTEBRAL DISC PROTRUSION 13 0.0006
597 HEMIPARESIS 10 0.0006
598 PALLOR 16 0.0006
599 ABNORMAL LOSS OF WEIGHT 4 0.0006
600 EUPHORIC MOOD 6 0.0006
601 ANURIA 5 0.0006
602 DELUSION 9 0.0006
603 CARDIAC MURMUR 5 0.0006
604 MENTAL IMPAIRMENT 14 0.0006
605 HYSTERECTOMY 5 0.0006
606 UNDERDOSE 42 0.0006
607 NECK PAIN 32 0.0006
608 URINE OUTPUT DECREASED 5 0.0006
609 FEELING HOT 35 0.0006
610 CARDIOMEGALY 7 0.0006
611 GAIT INABILITY 19 0.0006
612 SPINAL OPERATION 7 0.0006
613 COLD SWEAT 10 0.0006
614 LUNG INFILTRATION 5 0.0006
615 ACUTE RESPIRATORY DISTRESS SYNDROME 10 0.0006
616 HYPOKALAEMIA 26 0.0006
617 CHILLS 66 0.0006
618 HAEMOLYTIC ANAEMIA 5 0.0006
619 CARDIOGENIC SHOCK 8 0.0006
620 BLOOD CREATINE PHOSPHOKINASE INCREASED 16 0.0006
621 SYNOVITIS 10 0.0006
622 PARAESTHESIA ORAL 8 0.0006
623 SPEECH DISORDER 29 0.0006
624 LEUKOCYTOSIS 10 0.0006
625 MUSCLE ATROPHY 7 0.0006
626 OSTEOMYELITIS 10 0.0006
627 LUPUS-LIKE SYNDROME 5 0.0006
628 DYSURIA 20 0.0005
629 OBSTRUCTIVE AIRWAYS DISORDER 6 0.0005
630 PHARMACEUTICAL PRODUCT COMPLAINT 14 0.0005
631 RESPIRATORY TRACT INFECTION 14 0.0005
632 WOUND 15 0.0005
633 MUSCULOSKELETAL STIFFNESS 47 0.0005
634 HAEMORRHAGE 56 0.0005
635 JOINT STIFFNESS 14 0.0005
636 BEDRIDDEN 7 0.0005
637 HALLUCINATION 40 0.0005
638 ABNORMAL BEHAVIOUR 21 0.0005
639 CONTRAINDICATED PRODUCT ADMINISTERED 16 0.0005
640 CONDITION AGGRAVATED 160 0.0005
641 VOMITING 247 0.0005
642 DYSGEUSIA 39 0.0005
643 SUPRAVENTRICULAR TACHYCARDIA 5 0.0005
644 PNEUMONIA ASPIRATION 13 0.0005
645 TREATMENT FAILURE 43 0.0005
646 BRAIN FOG 8 0.0005
647 PERIPHERAL COLDNESS 7 0.0005
648 RENAL TUBULAR NECROSIS 5 0.0005
649 BACTERAEMIA 6 0.0005
650 PREGNANCY 10 0.0005
651 FIBROMYALGIA 12 0.0005
652 GLOSSODYNIA 11 0.0005
653 NEUTROPHIL COUNT INCREASED 5 0.0005
654 TREMOR 80 0.0005
655 BREAST CANCER STAGE II 4 0.0005
656 SWOLLEN TONGUE 15 0.0005
657 TENDERNESS 5 0.0005
658 PHOTOPHOBIA 9 0.0005
659 OEDEMA PERIPHERAL 58 0.0005
660 BALANCE DISORDER 41 0.0005
661 MUSCULOSKELETAL DISORDER 9 0.0005
662 NAUSEA 373 0.0005
663 ANXIETY 134 0.0005
664 HEPATITIS 12 0.0005
665 ROTATOR CUFF SYNDROME 6 0.0005
666 INFUSION SITE PAIN 6 0.0005
667 PARANOIA 8 0.0005
668 DRUG INEFFECTIVE 608 0.0005
669 AMNESIA 30 0.0005
670 PLEURAL EFFUSION 28 0.0005
671 BACK INJURY 5 0.0005
672 LOCAL SWELLING 8 0.0005
673 DRUG DISPENSING ERROR 7 0.0005
674 ASTHENIA 172 0.0005
675 INJURY 32 0.0005
676 LIMB DISCOMFORT 14 0.0005
677 FOOT DEFORMITY 5 0.0005
678 INTESTINAL OBSTRUCTION 17 0.0005
679 EJECTION FRACTION DECREASED 7 0.0004
680 TYPE 2 DIABETES MELLITUS 15 0.0004
681 MOBILITY DECREASED 32 0.0004
682 C-REACTIVE PROTEIN INCREASED 16 0.0004
683 AKATHISIA 6 0.0004
684 CONSTIPATION 95 0.0004
685 PULMONARY HYPERTENSION 9 0.0004
686 CARPAL TUNNEL SYNDROME 6 0.0004
687 HEPATIC CIRRHOSIS 8 0.0004
688 SKIN ULCER 11 0.0004
689 EPILEPSY 13 0.0004
690 ARTERIOSCLEROSIS 4 0.0004
691 DRUG LEVEL INCREASED 7 0.0004
692 WHEEZING 25 0.0004
693 CHRONIC KIDNEY DISEASE 32 0.0004
694 AFFECT LABILITY 4 0.0004
695 SEPTIC SHOCK 18 0.0004
696 DYSSTASIA 12 0.0004
697 PRODUCT USE ISSUE 77 0.0004
698 LIVER INJURY 10 0.0004
699 MUSCULOSKELETAL DISCOMFORT 7 0.0004
700 FALL 135 0.0004
701 ACTIVITIES OF DAILY LIVING IMPAIRED 8 0.0004
702 EXTRAPYRAMIDAL DISORDER 10 0.0004
703 PRESCRIBED UNDERDOSE 8 0.0004
704 ABDOMINAL PAIN 93 0.0004
705 CELLULITIS 20 0.0004
706 ECONOMIC PROBLEM 6 0.0004
707 DYSPHONIA 23 0.0004
708 BODY TEMPERATURE INCREASED 8 0.0004
709 PAIN IN EXTREMITY 115 0.0004
710 ATRIAL FIBRILLATION 38 0.0004
711 OSTEOPOROSIS 16 0.0004
712 MULTIPLE ORGAN DYSFUNCTION SYNDROME 11 0.0004
713 ANKLE FRACTURE 6 0.0004
714 SWELLING 36 0.0004
715 PANIC ATTACK 14 0.0004
716 SWELLING FACE 25 0.0004
717 RHABDOMYOLYSIS 16 0.0004
718 PLATELET COUNT INCREASED 5 0.0004
719 SLEEP DISORDER 27 0.0004
720 INCORRECT DOSE ADMINISTERED BY DEVICE 10 0.0004
721 ARRHYTHMIA 18 0.0004
722 THERAPEUTIC PRODUCT EFFECT DECREASED 17 0.0004
723 IMMUNE SYSTEM DISORDER 5 0.0004
724 GAIT DISTURBANCE 72 0.0004
725 QUALITY OF LIFE DECREASED 5 0.0004
726 FEAR 10 0.0004
727 DIZZINESS 185 0.0004
728 HYPERSENSITIVITY 68 0.0004
729 PULMONARY FIBROSIS 7 0.0004
730 PSYCHOMOTOR HYPERACTIVITY 6 0.0004
731 COAGULOPATHY 6 0.0004
732 FEELING COLD 10 0.0004
733 HYPOMAGNESAEMIA 5 0.0004
734 SURGERY 21 0.0004
735 BLINDNESS UNILATERAL 5 0.0004
736 DISABILITY 7 0.0004
737 HEPATOCELLULAR INJURY 5 0.0004
738 DISTURBANCE IN ATTENTION 19 0.0004
739 CHEST PAIN 65 0.0004
740 SYNCOPE 35 0.0003
741 SEPSIS 39 0.0003
742 HYPOACUSIS 15 0.0003
743 IMPAIRED QUALITY OF LIFE 5 0.0003
744 URTICARIA 58 0.0003
745 HYPERTHYROIDISM 5 0.0003
746 HOSPITALISATION 53 0.0003
747 HYPOKINESIA 5 0.0003
748 DEAFNESS 9 0.0003
749 APATHY 5 0.0003
750 MEMORY IMPAIRMENT 47 0.0003
751 ALANINE AMINOTRANSFERASE INCREASED 21 0.0003
752 NIGHT SWEATS 11 0.0003
753 RIB FRACTURE 7 0.0003
754 ANGIOEDEMA 15 0.0003
755 WHITE BLOOD CELL COUNT INCREASED 13 0.0003
756 PRODUCT QUALITY ISSUE 46 0.0003
757 PSYCHOTIC DISORDER 10 0.0003
758 BLISTER 19 0.0003
759 CARDIOMYOPATHY 5 0.0003
760 DRUG EFFECT LESS THAN EXPECTED 5 0.0003
761 POLLAKIURIA 14 0.0003
762 ACUTE KIDNEY INJURY 51 0.0003
763 KNEE ARTHROPLASTY 7 0.0003
764 HAEMOGLOBIN DECREASED 34 0.0003
765 HYPOGLYCAEMIA 16 0.0003
766 INFLAMMATION 17 0.0003
767 DYSPNOEA 186 0.0003
768 SKIN LESION 9 0.0003
769 DEEP VEIN THROMBOSIS 21 0.0003
770 THINKING ABNORMAL 6 0.0003
771 BACTERIAL INFECTION 6 0.0003
772 EXTRA DOSE ADMINISTERED 13 0.0003
773 THERAPY PARTIAL RESPONDER 5 0.0003
774 DEVICE BREAKAGE 13 0.0003
775 NIGHTMARE 11 0.0003
776 IRRITABILITY 19 0.0003
777 NEUROPATHY PERIPHERAL 30 0.0003
778 FEELING JITTERY 6 0.0003
779 ANGINA PECTORIS 9 0.0003
780 HYPOPHAGIA 8 0.0003
781 DRUG RESISTANCE 8 0.0003
782 ANOREXIA 4 0.0003
783 PRURITUS 119 0.0003
784 HEPATIC ENZYME INCREASED 21 0.0003
785 INSOMNIA 82 0.0003
786 BLOOD PRESSURE SYSTOLIC INCREASED 6 0.0003
787 ANHEDONIA 8 0.0003
788 COMPLICATION OF DEVICE INSERTION 6 0.0003
789 CONTUSION 29 0.0003
790 ASPARTATE AMINOTRANSFERASE INCREASED 16 0.0003
791 SPINAL FRACTURE 6 0.0003
792 CARDIAC DISORDER 28 0.0003
793 DEPRESSION 68 0.0003
794 MENTAL DISORDER 13 0.0003
795 PRODUCT USE IN UNAPPROVED INDICATION 74 0.0003
796 DRY MOUTH 24 0.0003
797 DYSPHAGIA 28 0.0003
798 PULMONARY EMBOLISM 28 0.0003
799 NO ADVERSE EVENT 53 0.0003
800 VISION BLURRED 40 0.0003
801 CENTRAL NERVOUS SYSTEM LESION 4 0.0003
802 THERAPEUTIC RESPONSE UNEXPECTED 13 0.0003
803 TOOTH LOSS 6 0.0003
804 LUNG DISORDER 14 0.0003
805 INFECTION 41 0.0003
806 CHEST DISCOMFORT 29 0.0003
807 SKIN DISCOLOURATION 13 0.0003
808 LYMPHOCYTE COUNT DECREASED 5 0.0003
809 MALAISE 124 0.0003
810 DRUG INTOLERANCE 27 0.0003
811 HYPERSOMNIA 8 0.0003
812 POOR QUALITY SLEEP 6 0.0003
813 GASTROENTERITIS VIRAL 5 0.0003
814 CARDIOVASCULAR DISORDER 7 0.0003
815 CRYING 10 0.0003
816 INFUSION RELATED REACTION 18 0.0003
817 RENAL FAILURE 36 0.0003
818 PYREXIA 93 0.0003
819 HEPATIC STEATOSIS 5 0.0003
820 INFLUENZA LIKE ILLNESS 22 0.0003
821 HEADACHE 167 0.0003
822 BLOOD SODIUM DECREASED 5 0.0003
823 ILL-DEFINED DISORDER 16 0.0003
824 FEELING ABNORMAL 63 0.0003
825 SUICIDAL IDEATION 24 0.0003
826 THROAT TIGHTNESS 7 0.0003
827 CHOKING 5 0.0003
828 ORAL HERPES 5 0.0003
829 FLUSHING 26 0.0003
830 WEIGHT DECREASED 71 0.0003
831 INCORRECT DOSE ADMINISTERED 58 0.0003
832 BLOOD LACTATE DEHYDROGENASE INCREASED 4 0.0003
833 RASH ERYTHEMATOUS 12 0.0003
834 MOOD SWINGS 8 0.0003
835 ABSCESS 4 0.0003
836 ELECTROCARDIOGRAM QT PROLONGED 9 0.0002
837 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 13 0.0002
838 JOINT SWELLING 30 0.0002
839 GASTROOESOPHAGEAL REFLUX DISEASE 20 0.0002
840 LIVER DISORDER 11 0.0002
841 PRESYNCOPE 6 0.0002
842 GASTROINTESTINAL DISORDER 22 0.0002
843 CEREBRAL INFARCTION 6 0.0002
844 DYSPEPSIA 24 0.0002
845 VISUAL IMPAIRMENT 30 0.0002
846 LOWER RESPIRATORY TRACT INFECTION 11 0.0002
847 THERAPEUTIC RESPONSE SHORTENED 8 0.0002
848 INTENTIONAL PRODUCT USE ISSUE 21 0.0002
849 PALPITATIONS 28 0.0002
850 DERMATITIS 5 0.0002
851 ERYTHEMA 49 0.0002
852 TRANSIENT ISCHAEMIC ATTACK 8 0.0002
853 CANDIDA INFECTION 4 0.0002
854 BLOOD CHOLESTEROL INCREASED 11 0.0002
855 RENAL INJURY 7 0.0002
856 RETCHING 5 0.0002
857 ARTHROPATHY 13 0.0002
858 DEHYDRATION 31 0.0002
859 PRURITUS GENERALISED 5 0.0002
860 NERVOUSNESS 12 0.0002
861 PRODUCT PRESCRIBING ISSUE 5 0.0002
862 URINARY TRACT INFECTION 39 0.0002
863 GASTRITIS 6 0.0002
864 EAR INFECTION 6 0.0002
865 SYSTEMIC LUPUS ERYTHEMATOSUS 8 0.0002
866 PLATELET COUNT DECREASED 24 0.0002
867 GENERAL PHYSICAL HEALTH DETERIORATION 26 0.0002
868 HEPATOTOXICITY 5 0.0002
869 RASH PAPULAR 5 0.0002
870 JAUNDICE 6 0.0002
871 FREQUENT BOWEL MOVEMENTS 6 0.0002
872 PSORIATIC ARTHROPATHY 9 0.0002
873 LIMB INJURY 6 0.0002
874 BLINDNESS 9 0.0002
875 DECREASED APPETITE 51 0.0002
876 BONE DISORDER 4 0.0002
877 TREATMENT NONCOMPLIANCE 12 0.0002
878 FLUID RETENTION 11 0.0002
879 ARTHRALGIA 89 0.0002
880 HYPONATRAEMIA 12 0.0002
881 RENAL FAILURE ACUTE 9 0.0002
882 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 15 0.0002
883 PNEUMONIA 68 0.0002
884 RED BLOOD CELL COUNT DECREASED 6 0.0002
885 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 10 0.0002
886 DIABETIC KETOACIDOSIS 5 0.0002
887 PANCREATIC CARCINOMA 6 0.0002
888 LIVER FUNCTION TEST ABNORMAL 6 0.0002
889 INTENTIONAL OVERDOSE 13 0.0002
890 OSTEONECROSIS OF JAW 5 0.0002
891 BLOOD PRESSURE ABNORMAL 4 0.0002
892 ABDOMINAL DISTENSION 21 0.0002
893 STOMATITIS 12 0.0002
894 VERTIGO 12 0.0002
895 SINUSITIS 20 0.0002
896 EYE PAIN 11 0.0002
897 UPPER RESPIRATORY TRACT INFECTION 9 0.0002
898 ERECTILE DYSFUNCTION 5 0.0002
899 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 5 0.0002
900 INTENTIONAL PRODUCT MISUSE 17 0.0002
901 RENAL DISORDER 9 0.0002
902 HYPERGLYCAEMIA 7 0.0002
903 MUCOSAL INFLAMMATION 5 0.0002
904 DISEASE PROGRESSION 22 0.0002
905 DYSPNOEA EXERTIONAL 7 0.0002
906 MALIGNANT NEOPLASM PROGRESSION 19 0.0002
907 MOOD ALTERED 5 0.0002
908 CHOLELITHIASIS 6 0.0002
909 LIP SWELLING 6 0.0002
910 ARTHRITIS 14 0.0002
911 ADVERSE EVENT 16 0.0002
912 HYPERKALAEMIA 6 0.0002
913 MYALGIA 29 0.0002
914 WEIGHT INCREASED 38 0.0002
915 FATIGUE 131 0.0002
916 DRUG ABUSE 14 0.0002
917 DRUG DEPENDENCE 27 0.0002
918 MIGRAINE 16 0.0002
919 HEPATIC FAILURE 5 0.0002
920 LACRIMATION INCREASED 5 0.0002
921 DRUG EFFECT INCOMPLETE 6 0.0002
922 PERIPHERAL SWELLING 25 0.0002
923 INJECTION SITE MASS 6 0.0002
924 EMOTIONAL DISORDER 5 0.0002
925 VAGINAL HAEMORRHAGE 7 0.0002
926 BLOOD ALKALINE PHOSPHATASE INCREASED 4 0.0002
927 ABDOMINAL DISCOMFORT 27 0.0002
928 ASTHMA 18 0.0002
929 MYOCARDIAL INFARCTION 27 0.0002
930 OSTEONECROSIS 5 0.0002
931 PANCREATITIS 8 0.0002
932 CATARACT 9 0.0002
933 EMOTIONAL DISTRESS 18 0.0001
934 MULTIPLE SCLEROSIS RELAPSE 10 0.0001
935 BLOOD GLUCOSE DECREASED 7 0.0001
936 FLATULENCE 8 0.0001
937 AGGRESSION 7 0.0001
938 DIARRHOEA 90 0.0001
939 WRONG TECHNIQUE IN DRUG USAGE PROCESS 5 0.0001
940 CARDIAC FAILURE 11 0.0001
941 ABDOMINAL PAIN UPPER 28 0.0001
942 EYE SWELLING 5 0.0001
943 HOT FLUSH 10 0.0001
944 COMPLETED SUICIDE 11 0.0001
945 ANAEMIA 25 0.0001
946 NEPHROLITHIASIS 6 0.0001
947 CEREBROVASCULAR ACCIDENT 22 0.0001
948 DRUG DOSE OMISSION 21 0.0001
949 MULTIPLE SCLEROSIS 6 0.0001
950 NASOPHARYNGITIS 23 0.0001
951 NEUTROPHIL COUNT DECREASED 5 0.0001
952 ALOPECIA 24 0.0001
953 HERPES ZOSTER 7 0.0001
954 LUNG NEOPLASM MALIGNANT 5 0.0001
955 DIABETES MELLITUS 9 0.0001
956 THROMBOCYTOPENIA 13 0.0001
957 THROMBOSIS 9 0.0001
958 THROAT IRRITATION 5 0.0001
959 ACCIDENTAL EXPOSURE TO PRODUCT 11 0.0001
960 NEOPLASM MALIGNANT 7 0.0001
961 DEATH 89 0.0001
962 BONE PAIN 6 0.0001
963 NASAL CONGESTION 6 0.0001
964 LEUKOPENIA 5 0.0001
965 SUICIDE ATTEMPT 6 0.0001
966 INFLUENZA 11 0.0001
967 RHEUMATOID ARTHRITIS 11 0.0001
968 DEPRESSED MOOD 5 0.0001
969 COUGH 25 0.0001
970 INJECTION SITE REACTION 6 0.0001
971 BRONCHITIS 6 0.0001
972 RASH 35 0.0001
973 BLOOD GLUCOSE INCREASED 15 0.0001
974 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 16 0.0001
975 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 14 0.0001
976 ILLNESS 8 0.0001
977 FEBRILE NEUTROPENIA 5 0.0001
978 CARDIAC FAILURE CONGESTIVE 6 0.0001
979 GASTROINTESTINAL HAEMORRHAGE 6 0.0001
980 RENAL IMPAIRMENT 6 0.0001
981 OROPHARYNGEAL PAIN 6 0.0001
982 WHITE BLOOD CELL COUNT DECREASED 7 0.0001
983 BREAST CANCER 6 0.0001
984 INJECTION SITE BRUISING 5 0.0001
985 BLOOD CREATININE INCREASED 4 0.0001
986 PSORIASIS 7 0.0001
987 DRY SKIN 7 0.0001
988 PRODUCT DOSE OMISSION ISSUE 15 0.0001
989 INJECTION SITE PAIN 15 0.0000